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Abstract Achacin is an antibacterial glycoprotein puri¢ed
from the mucus of the giant snail, Achatina fulica Fe¤russac,
as a humoral defense factor. We showed that achacin has
L-amino acid oxidase activity and can generate cytotoxic
H2O2 ; however, the concentration of H2O2 was not su⁄cient
to kill bacteria. The antibacterial activity of achacin was inhib-
ited by various H2O2 scavengers. Immunochemical analysis re-
vealed that achacin was preferentially bound to growth-phase
bacteria, accounting for the important role in growth-phase-de-
pendent antibacterial activity of achacin. Achacin may act as an
important defense molecule against invading bacteria.
( 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
We previously isolated [1] and cloned [2] an antibacterial
glycoprotein called achacin from the body surface mucus of
the giant snail, Achatina fulica Fe¤russac. Achacin shows
strong bactericidal activity against both Gram-positive and
-negative bacteria [3], and it appears to attack the plasma
membranes of bacteria [4]. Achacin is thought to contribute
to the innate immunity of the snail, but the mechanism by
which it does so has not been elucidated.
Recent sequence analysis revealed that achacin belongs to
the family of amine oxidases, which are £avin enzymes. This
family comprises various amine oxidases including L-amino
acid oxidase (LAO, EC 1.4.3.2). LAOs catalyze oxidative de-
amination of L-amino acids to produce the corresponding
K-ketoacids, hydrogen peroxide (H2O2), and ammonia
(NH3). Some LAOs have antibacterial properties [5], thus
we hypothesized that antibacterial activity of achacin is re-
lated to the H2O2 generated through the oxidative deamina-
tion reaction. Interestingly, snake LAOs cause induction of
apoptosis [6^8] and platelet aggregation [9,10] and have anti-
bacterial activity [5]. These e¡ects are thought to be due to
H2O2 produced by the enzyme.
Although LAOs exist widely among living organisms from
invertebrates to vertebrates, their functions in vivo are not
well understood. Here, we show that the H2O2-generating
LAO activity of achacin contributed to its antibacterial ac-
tion. Furthermore, we report that achacin speci¢cally recog-
nized growth-phase bacteria.
2. Materials and methods
2.1. Materials
Anti-rabbit IgG antiserum conjugated to horseradish peroxidase
was purchased from Dako Japan (Kyoto, Japan). Xylenol orange
was purchased from Chroma-Gesellschaft Schmid (Ko«ngen, Ger-
many). All other chemicals were purchased from Wako Pure Chem-
icals (Tokyo, Japan), Nacalai Tesque (Kyoto, Japan), or Sigma (St.
Louis, MO, USA).
2.2. Bacterial strains and media
Staphylococcus aureus (IAM1011) and Escherichia coli (K12
W3110) were used in this study. These strains were grown in heart
infusion bouillon medium (Eiken Chemical, Tokyo, Japan) and Lu-
ria^Bertani (LB) broth, respectively.
2.3. Measurement of antibacterial activity
Achacin was prepared from the mucus of the giant African snail,
A. fulica Fe¤russac, as described in [1]. Antibacterial activities of acha-
cin and H2O2 were examined with a metabolic inhibition assay [1].
S. aureus or E. coli (approximately 106 colony forming units/ml) were
cultured in 96-well plates in 100 Wl of heart infusion bouillon medium,
containing 1% glucose and test sample (dilution series of achacin or
H2O2) for 16 h at 37‡C. Antibacterial activity was determined by the
lack of bacterial pellet after the incubation. The number of surviving
cells was determined by the colony counting method as described
previously [11].
2.4. Measurement of LAO activity
Xylenol orange assay was performed as described previously [12].
For the standard assay, the following reagents were added sequen-
tially: 0.25 mM FeSO4, 25 mM H2SO4, 0.1 mM xylenol orange, and
distilled water to a total volume of 180 Wl. An aliquot (20 Wl) of each
sample was added to the mixture and incubated for 30 min at room
temperature. LAO activity was determined by measuring the absor-
bance of Fe3þ (from oxidation of Fe2þ by H2O2)^xylenol orange
complex at 550 nm. Blanks were prepared by replacing samples
with 0.15 M NaCl.
2.5. Microscopic analysis of achacin- or H2O2-treated E. coli
E. coli (107 cells) were cultured in 1 ml of LB broth containing
various concentration of achacin or H2O2. After incubation for 2 h
at 37‡C, bacterial suspensions were diluted 100-fold with sterilized
water, mounted on glass slides, and stained with basic fuchsine. Mor-
phology of E. coli was observed by light microscopy (Model BH-2-
RFL, Olympus Optical Corp., Tokyo, Japan). Bacterial length was
estimated by measuring the photo-images.
2.6. Analysis of bacteria-binding activity
Bacteria (108 cells) were cultured in 10 ml of LB broth for 2 h at
37‡C. Bacteria were collected by centrifugation at 1000Ug for 10 min,
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washed with 1 ml of phosphate-bu¡ered saline (PBS) once, and sus-
pended in 1 ml of 0.15 M NaCl. Then 50 Wl of each bacterial suspen-
sion was added to 450 Wl of either LB broth or 0.15 M NaCl both
containing 5 Wg/ml of achacin and/or N-acetylneuraminic acid (Neu5-
Ac) and incubated for 2 h at 37‡C. Bacterial proteins were collected
by centrifugation of cells at 1000Ug for 10 min, washing with 1 ml of
PBS twice, and sonication at weak power in 6 M urea containing 1%
Triton X-100. Protein concentrations were determined according to
the method of Bradford [13]. Achacin in the lysate that had bound to
bacteria was detected by SDS^PAGE followed by Western blot anal-
ysis.
2.7. SDS^PAGE and Western blot analysis
SDS^PAGE was performed according to the method of Laemmli
[14] using 12.5% gels. Western blot analysis was done with anti-acha-
cin polyclonal antibody as reported previously [11].
3. Results
3.1. LAO activity of achacin
Alignment of amino acid sequences showed that the char-
acteristic £avin-binding site of amine oxidases was well con-
served in achacin (Fig. 1). The oxidation activity of achacin
was characterized for substrate speci¢city through analysis of
various amino acids as substrates. Achacin showed high oxi-
dase activity (2.62 U/mg) against L-Leu (Fig. 2A) similar to
other LAOs [6,7,10]. Furthermore, achacin oxidized various
L-type amino acids, whereas D-type amino acids were not oxi-
dized, indicating that achacin is an LAO with broad substrate
speci¢city for L-type amino acids (Fig. 2B).
3.2. Contribution of generated H2O2 to the antibacterial
activity of achacin
Several LAOs from snake venoms show antibacterial and
cytotoxic activities, and the H2O2 generated through the en-
zymatic reaction appears to be involved in these activities
[6,15,16]. To examine the contribution of the generated
H2O2 to the antibacterial activity of achacin, we measured
the antibacterial activity of achacin against both Gram-posi-
tive (S. aureus) and -negative (E. coli) bacteria in the presence
of several H2O2 scavengers. The antibacterial activity of acha-
cin (2 Wg/ml) was clearly inhibited by all scavengers tested
(Table 1), suggesting that H2O2 is a mediator of the antibac-
terial activity.
We previously reported that achacin induces extensive ¢la-
mentation of E. coli [4]. A similar morphological change was
also observed in E. coli treated with a low concentration of
H2O2 [17]. We compared the dose-dependent morphological
changes in E. coli in the presence of achacin or H2O2 (Fig. 3).
Cell ¢lamentation was observed in H2O2-treated E. coli up to
the minimum inhibitory concentration (MIC) (Fig. 3A,B);
however, no obvious changes were observed at higher concen-
Fig. 1. Alignment of the amino acid sequences of the N-terminus of achacin and the amine oxidase consensus region. Solid underline indicates
£avin-binding sites. Broken line indicates amino acids that are also conserved in £avin enzymes [29]. MAO, monoamine oxidase; PAO, poly-
amine oxidase; PUO, putrescine oxidase.
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Fig. 2. LAO activity of achacin. A: Time- and amino acid type-de-
pendent production of H2O2. L-Leu or D-Leu (10 mM) was used as
substrate. B: L-Amino acid species-speci¢c LAO activity of achacin.
One unit (U) was de¢ned as the amount that deaminizes 1 Wmol of
L-amino acid per min. Data represent meanRS.D. (bar) of three in-
dependent experiments.
Table 1
Inhibitory e¡ect of H2O2 decomposers on antimicrobial activity of
achacin
Substance Inhibitory concentrationa
S. aureus E. coli
MnO2 0.5 mg/mlb 0.5 mg/mlb
FeSO4 250 WM 250 WM
Catalase 0.03 Ud 0.25 U
HRPc 0.02 U 0.08 U
aIncubated with 2 Wg/ml of achacin under MIC measurement condi-
tion.
bConcentration as a suspension.
cHRP: horseradish peroxidase.
dU: unit.
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trations (four-fold higher than the MIC) (Fig. 3C). Similar
morphological changes were also observed in achacin-treated
E. coli (Fig. 3D^F). Statistical analyses revealed that the
peaks of the achacin and H2O2 ¢lamentation activities corre-
sponded to the MICs and appeared to accompany the acute
reduction in the number of surviving cells (Fig. 3H). These
data indicate that the morphological changes observed in
achacin-treated E. coli are due primarily to the generated
H2O2.
To con¢rm our observation, we examined the time-depen-
dent H2O2 productivity of achacin under the conditions we
used for measurement of antibacterial activity. At MICs for
S. aureus (0.2 Wg/ml) and E. coli (2 Wg/ml), achacin produced
0.2 and 0.4 mM H2O2, respectively (Table 2). However, the
MICs of H2O2 that we determined under the same conditions
were 0.7 mM (against S. aureus) and 1 mM (against E. coli)
(Table 2). This inconsistency suggests that achacin has a novel
function that allows for maximal antibacterial action.
3.3. Bacteria-binding activity of achacin
The growth-phase-speci¢c antibacterial activity and bacte-
rial plasma membrane localization of achacin were reported
previously [3,4]. Thus, we hypothesized that achacin binds to
bacterial plasma membrane in a growth-phase-speci¢c manner
and that this allows achacin to kill bacteria with a lower con-
centration of H2O2. To con¢rm this hypothesis, we examined
the bacteria-binding activity of achacin by Western blotting
(Fig. 4). Achacin incubated with culture medium (growth con-
dition) showed signi¢cant bacteria-binding activity against
S. aureus and E. coli (Fig. 4A, lanes 2 and 5). In contrast,
achacin incubated with physiological saline (rest condition)
showed only slight binding (Fig. 4A, lanes 1 and 4), indicating
that achacin preferentially recognizes the growth-phase bacte-
ria. In addition, the binding activity was higher against
S. aureus than against E. coli, which is consistent with the
observed di¡erences in MICs between S. aureus (0.2 Wg/ml)
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Fig. 3. Comparison of the morphological changes in achacin- and
H2O2-treated E. coli. Morphology of achacin-treated (A^C) or
H2O2-treated (D^F) E. coli was observed by light microscopy.
MICs of achacin and H2O2 were each de¢ned as 1 unit. A^C:
E. coli treated with 0.5, 1, and 4 units of achacin, respectively.
D^F: E. coli treated with 0.5, 1, and 4 units of H2O2, respectively.
G: Physiological saline control. H: Statistical representation of mor-
phological changes and survival of E. coli. The bacterial lengths of
E. coli treated with achacin (solid bars, n=40) and H2O2 (open
bars, n=40) were measured. The numbers of E. coli surviving after
treatment with achacin (solid circles) and H2O2 (open circles) were
determined by the colony counting method [3]. Arrowhead indicates
MIC.
Table 2
Comparison of MICs between achacin and H2O2
Bacteria MICs
Achacin H2O2
S. aureus 0.2 Wg/ml (0.2 mM)a 0.7 mM
E. coli 2 Wg/ml (0.5 mM)a 1 mM
aIncubation with achacin was up to 24 h. Maximal H2O2 concentra-
tion at indicated achacin concentrations was detected at approxi-
mately 2 h incubation.
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Fig. 4. Bacteria-binding activity of achacin. A: Bacteria-binding ac-
tivity of achacin against both Gram-positive (S. aureus) and -nega-
tive (E. coli) bacteria under rest conditions (R) and growth condi-
tions (G). B: E¡ect of sialic acid on the bacteria-binding activity of
achacin against S. aureus was examined in the presence of Neu5Ac.
C: Inhibitory e¡ect of Neu5Ac on the LAO activity of achacin. The
LAO activity of achacin was measured in the presence (square, 0.5
mg/ml; triangle, 2 mg/ml) and absence (circle) of Neu5Ac. CBB,
Coomassie brilliant blue staining; WB, Western blotting with anti-
achacin antibody.
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and E. coli (2 Wg/ml). These results indicate that binding to
bacteria is important for the antibacterial activity of achacin.
Aplysianin E, the putative processed form of aplysianin A
that shows homology to achacin [18], also has antibacterial
and antitumor activities [19,20]. The tumor lysis activity of
aplysianin E was inhibited by Neu5Ac, suggesting that recog-
nition of a sugar moiety is a key step in this process [19]. In a
preliminary study, we also found that the antibacterial and
cytotoxic activities of achacin were inhibited by Neu5Ac (data
not shown). Therefore, we investigated whether Neu5Ac af-
fects the bacteria recognition or LAO activity of achacin (Fig.
4B,C). Up to 2 mg/ml of Neu5Ac did not block the bacteria-
binding activity of achacin (Fig. 4B, lane 3), and higher con-
centrations of Neu5Ac inhibited bacterial growth (data not
shown). In contrast, Neu5Ac inhibited the LAO enzyme ac-
tivity (Fig. 4C); this inhibition should be su⁄cient to diminish
the antibacterial activity of achacin.
4. Discussion
In the present study, we show that the antibacterial activity
of achacin is due to H2O2 generated by LAO activity. How-
ever, the concentration of achacin-generated H2O2 in the cul-
ture medium was not su⁄cient to inhibit bacterial growth.
Growth-phase-speci¢c bacteria binding appeared to play an
important role in the antibacterial activity of achacin. In
fact, Suhr et al. [21] reported that LAO from snake venom
bound to the cell surface in a cell-selective manner. This se-
lectivity is thought to lead to the cell-speci¢c cytotoxicity of
the LAO through locally increased H2O2 [21]. These data
suggest that when snails are infected by pathogens, achacin
should bind to the plasma membranes of those that are pro-
liferating. Achacin may attack pathogens during other growth
phases by increasing the local concentration of H2O2 so as not
to harm neighboring host cells.
Despite many studies, the substance or structure recognized
by achacin has not yet been determined. Neu5Ac, which is a
sialic acid, is reported to act as a potent inhibitor of the
antitumor activity displayed by some antitumor glycoproteins
isolated from mollusks [19,22,23]. However, our data showed
that Neu5Ac inhibited the antibacterial activity of achacin
through inhibition of the LAO activity and not through inhi-
bition of the bacteria-binding activity. Thus, recognition of
sugar moieties should not be essential for the antibacterial
activity of achacin. Cytotoxic cyplasin was recently isolated
from the mucus of the European sea hare, A. punctata [24],
and it shows signi¢cant amino acid sequence similarity to
achacin. The cytotoxic action of cyplasin is preferential to
growing cells [24], as is the antibacterial activity of achacin.
In mollusks, these antibacterial and cytotoxic glycoproteins
are localized to mucus [1,24], albumen gland, egg, purple £u-
id, and coelomic £uid [23]. Because these tissues and £uids act
as the organism’s ¢rst line of defense against the external
environment, the putative biological functions of these glyco-
proteins might be as defense factors.
In higher vertebrates, a ¢sh LAO (AIP, [7,15]), interleukin 4
(IL-4)-induced gene (Fig1, [25^27]), and mouse milk LAO [28]
are reported to work as host defense factors. Thus, LAOs,
which are widely distributed in living organisms, appeared
to be important in both vertebrate and invertebrate host de-
fenses.
In the present study we showed that achacin preferentially
recognizes and binds to growth-phase bacteria to kill them
with H2O2 generated locally. Furthermore, this selective tox-
icity suggests that achacin might be useful as a multifunctional
chemotherapeutic agent because it may be more toxic to pro-
liferating pathogens than to host cells or normal £ora, which
have slower growth rates.
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